Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $75
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the price target from $85 to $75.
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the price target from $85 to $75.